Q1 2021 Holdings
Filed 2021-05-12 | 260 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $262.9M | 954,554 | 16.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $234.3M | 4,537,092 | 14.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $229.7M | 1,627,114 | 14.1% |
| Biogen Inc(BIIB) | COM | 09062X103 | $156.2M | 558,400 | 9.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $136.9M | 2,071,503 | 8.4% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $89.9M | 2,326,787 | 5.5% |
| Centene Corp del(CNC) | COM | 15135B101 | $82.5M | 1,290,597 | 5.1% |
| Align Technology Inc(ALGN) | COM | 016255101 | $78.0M | 143,960 | 4.8% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $57.2M | 100,202 | 3.5% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $54.6M | 188,385 | 3.4% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $54.4M | 2,243,000 | 3.3% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $45.4M | 566,821 | 2.8% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $41.6M | 384,100 | 2.6% |
| Atricure Inc(ATRC) | COM | 04963C209 | $32.6M | 497,712 | 2.0% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $20.8M | 59,700 | 1.3% |
| Avantor Inc(AVTR) | COM | 05352A100 | $14.8M | 512,216 | 0.9% |
| Caredx Inc(CDNA) | COM | 14167L103 | $13.0M | 190,371 | 0.8% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $5.0M | 45,500 | 0.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $2.8M | 37,000 | 0.2% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $2.1M | 75,000 | 0.1% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $2.0M | 15,500 | 0.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.7M | 65,900 | 0.1% |
| Cellectis S A(CLLS) | SPON ADS | 15117K103 | $1.7M | 83,500 | 0.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $403.9K | 8,984,234 | 0.0% |
| Carmax Inc(KMX) | COM | 143130102 | $378.0K | 2,850 | 0.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $368.0K | 2,809,950 | 0.0% |
| Constellation Brands Inc(STZ) | CL A | 21036P108 | $333.0K | 1,459 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $318.5K | 3,274,551 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $295.8K | 1,376,704 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $244.3K | 3,005,700 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $200.1K | 1,308,728 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $192.0K | 6,027,926 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $182.2K | 2,209,336 | 0.0% |
| Abbott Labs(ABT) | COM | 002824100 | $166.9K | 1,392,999 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $163.1K | 220,775 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $157.1K | 7,531,414 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $138.4K | 385,548 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $135.5K | 1,810,704 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $133.0K | 357,381 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $131.6K | 2,085,152 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $125.6K | 3,011,966 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $124.2K | 3,659,919 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $121.0K | 288,719 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $119.2K | 978,384 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $113.3K | 434,188 | 0.0% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $112.1K | 460,965 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $111.9K | 3,989,164 | 0.0% |
| Cigna Corp New(CI) | COM | 125523100 | $108.3K | 448,162 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $108.0K | 2,131,125 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $106.9K | 5,194,039 | 0.0% |